Medtronic plc (LON:0Y6X)

London flag London · Delayed Price · Currency is GBP · Price in USD
96.48
-1.69 (-1.72%)
At close: Oct 9, 2025
-1.72%
Market Cap93.07B
Revenue (ttm)25.45B
Net Income (ttm)3.47B
Shares Outn/a
EPS (ttm)2.69
PE Ratio26.84
Forward PE16.83
Dividend2.14 (2.18%)
Ex-Dividend DateSep 26, 2025
Volume3,064
Average Volume4,181
Open98.00
Previous Close98.17
Day's Range96.03 - 98.29
52-Week Range79.31 - 100.00
Beta0.79
RSI56.38
Earnings DateNov 18, 2025

About Medtronic

Medtronic plc develops, manufactures, and sells device-based medical therapies to healthcare systems, physicians, clinicians, and patients in the United States, Ireland, and internationally. The Cardiovascular Portfolio segment offers implantable cardiac pacemakers, cardioverter defibrillators, and cardiac resynchronization therapy devices; cardiac ablation products; insertable cardiac monitor systems; TYRX products; and remote monitoring and patient-centered software. It also provides aortic valves, surgical valve replacement and repair produc... [Read more]

Industry Medical - Equipment & Services
Sector Healthcare
Founded 1949
Employees 95,000
Stock Exchange London Stock Exchange
Ticker Symbol 0Y6X
Full Company Profile

Financial Performance

In 2025, Medtronic's revenue was $33.54 billion, an increase of 3.62% compared to the previous year's $32.36 billion. Earnings were $4.66 billion, an increase of 26.82%.

Financial numbers in USD Financial Statements

News

Medtronic plc - Special Call

Medtronic plc - Special CallCompany ParticipantsRyan Weispfenning - VP & Head of Investor RelationsEmily ElswickConference Call ParticipantsRyan...

1 day ago - Seeking Alpha

Stifel Raises Medtronic (MDT) Price Target to $105, Maintains Hold Rating | MDT Stock News

Stifel Raises Medtronic (MDT) Price Target to $105, Maintains Hold Rating | MDT Stock News

1 day ago - GuruFocus

November 28th Options Now Available For Medtronic (MDT)

Investors in Medtronic PLC (Symbol: MDT) saw new options begin trading today, for the November 28th expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the MDT options ...

1 day ago - Nasdaq

Medtronic BrainSense™ Adaptive Deep Brain Stimulation named a 2025 TIME Best Inventions

TIME Best Inventions honors extraordinary innovations changing lives DUBLIN , Oct. 9, 2025 /PRNewswire/ -- Medtronic plc (NYSE: MDT), a global leader in healthcare technology, today announced that Bra...

1 day ago - PRNewsWire

Orchestra BioMed to Showcase Transformative Potential of AVIM Therapy in Keynote Presentation on Hypertensive Heart Disease at Georgia Innovation Summit

Presentation to provide comprehensive overview of AVIM Therapy clinical evidence demonstrating the potential to halt the progression of hypertensive heart disease Orchestra BioMed and Medtronic (NYSE:...

1 day ago - GlobeNewsWire

Medtronic Kicks Off US Study On Robot-Assisted Surgeries For Women

Medtronic announces U.S. clinical ... Full story available on Benzinga.com

2 days ago - Benzinga

Medtronic (MDT) Launches Clinical Study for Robotic Surgery System

Medtronic (MDT) Launches Clinical Study for Robotic Surgery System

2 days ago - GuruFocus

Medtronic initiates U.S. IDE clinical study evaluating Hugo™ robotic-assisted surgery system for gynecological procedures

First procedures completed and enrollment underway in Embrace Gynecology study, furthering the company's progress to expand minimally invasive treatment options to patients in the United States GALWAY...

2 days ago - PRNewsWire

Medtronic (MDT) Receives Buy Rating and Increased Price Target from Citigroup | MDT Stock News

Medtronic (MDT) Receives Buy Rating and Increased Price Target from Citigroup | MDT Stock News

3 days ago - GuruFocus

Medtronic (MDT) Announces Successful €1.5 Billion Notes Offering

Medtronic (MDT) Announces Successful €1.5 Billion Notes Offering

11 days ago - GuruFocus

Medtronic Announces Closing of Public Offering of €1.5 Billion of Senior Notes

GALWAY, Ireland , Sept. 29, 2025 /PRNewswire/ -- Medtronic plc (the "Company") (NYSE: MDT) announced today that its wholly-owned indirect subsidiary, Medtronic, Inc., has closed a registered public of...

11 days ago - PRNewsWire

Medtronic Announces Closing of Public Offering of €1.5 Billion of Senior Notes

GALWAY , Ireland , Sept. 29, 2025 /PRNewswire/ -- Medtronic plc (the "Company") (NYSE: MDT) announced today that its wholly-owned indirect subsidiary, Medtronic, Inc., has closed a registered public ...

11 days ago - Benzinga

Medtronic (MDT) Suffers a Larger Drop Than the General Market: Key Insights

In the closing of the recent trading day, Medtronic (MDT) stood at $94.3, denoting a -1.5% move from the preceding trading day.

14 days ago - Nasdaq

Medtronic: FY26 Outlook Strengthened By New Product Launches

Medtronic (MDT) is undervalued, with strong organic growth and an 11% upside to a $105 target price, supporting a Buy rating. MDT's innovation pipeline, portfolio transformation, and spin-off of the d...

15 days ago - Seeking Alpha

Medtronic plc (MDT) Presents at Bank of America Global Healthcare Conference 2025 Transcript

Medtronic plc (NYSE:MDT) Bank of America Global Healthcare Conference 2025 September 24, 2025 9:10 AM EDT Company Participants Thierry Pieton - Executive VP & CFO Presentation Unknown Analyst We're g...

16 days ago - Seeking Alpha

1 Reason Medtronic (MDT) Is One of the Best Healthcare Stocks You Can Buy Today

Medtronic is one of the largest medical device makers in the world, and it is focused on getting more profitable.

18 days ago - The Motley Fool

Medtronic (MDT) Shares Cross 3% Yield Mark

Looking at the universe of stocks we cover at Dividend Channel, in trading on Friday, shares of Medtronic PLC (Symbol: MDT) were yielding above the 3% mark based on its quarterly dividend (annualized ...

21 days ago - Nasdaq

FDA Greenlights Medtronic's (MDT) Bladder Control Device

FDA Greenlights Medtronic's (MDT) Bladder Control Device

21 days ago - GuruFocus

Strategy To YieldBoost Medtronic To 9.9% Using Options

Shareholders of Medtronic PLC (Symbol: MDT) looking to boost their income beyond the stock's 3% annualized dividend yield can sell the March 2026 covered call at the $100 strike and collect the premiu...

21 days ago - Nasdaq

Medtronic gets FDA nod for the Altaviva device

Medtronic’s Altaviva bladder control device earns FDA approval for urge urinary incontinence. Read more here.

21 days ago - Seeking Alpha

Medtronic (MDT) Gains FDA Approval for Altaviva Device

Medtronic (MDT) Gains FDA Approval for Altaviva Device

21 days ago - GuruFocus

Medtronic secures FDA approval for the Altaviva™ device, a simple experience for treating urge urinary incontinence

The Implantable Tibial Neuromodulation (ITNM) device will expand treatment options for the 16 million people living with urinary urges and involuntary leaks GALWAY, Ireland , Sept. 19, 2025 /PRNewswir...

21 days ago - PRNewsWire

Medtronic (MDT) Up 1.5% Since Last Earnings Report: Can It Continue?

Medtronic (MDT) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

22 days ago - Nasdaq